ID: ALA2070515

Max Phase: Preclinical

Molecular Formula: C26H39N2O11P

Molecular Weight: 586.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(OP(=O)(O[C@H]2[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]2NC(C)=O)N2CCC[C@H]2C(=O)OC2CCCCC2)cc1

Standard InChI:  InChI=1S/C26H39N2O11P/c1-16(30)27-22-24(23(31)21(15-29)37-26(22)33)39-40(34,38-19-12-10-17(35-2)11-13-19)28-14-6-9-20(28)25(32)36-18-7-4-3-5-8-18/h10-13,18,20-24,26,29,31,33H,3-9,14-15H2,1-2H3,(H,27,30)/t20-,21+,22+,23+,24+,26-,40?/m0/s1

Standard InChI Key:  RYKIMJFQYOOLED-JBVMDQCASA-N

Associated Targets(non-human)

Cartilage 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 586.58Molecular Weight (Monoisotopic): 586.2291AlogP: 1.48#Rotatable Bonds: 10
Polar Surface Area: 173.32Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.55CX Basic pKa: CX LogP: 0.45CX LogD: 0.45
Aromatic Rings: 1Heavy Atoms: 40QED Weighted: 0.23Np Likeness Score: 0.68

References

1. Serpi M, Bibbo R, Rat S, Roberts H, Hughes C, Caterson B, Alcaraz MJ, Gibert AT, Verson CR, McGuigan C..  (2012)  Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explants.,  55  (10): [PMID:22501024] [10.1021/jm300074y]

Source